Open access · CC-BY
via OpenAlex
DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho−/− mice
Yu Hasegawa, Kenyu Hayashi, Yushin Takemoto, Cao Cheng, Koki Takane, Bowen Lin, Yoshihiro Komohara, Shokei Kim‐Mitsuyama
Cardiovascular Diabetology · 2017 · ▲ 31 citations
Abstract
BACKGROUND: The potential of anti-aging effect of DPP-4 inhibitors is unknown. This study was performed to determine whether linagliptin, a DPP-4 inhibitor, could protect against premature aging in klotho-/- mice. METHODS: Klotho-/- mice exhibit multiple phenotypes resembling human premature aging, including extremely shortened life span, cognitive impairment, hippocampal neurodegeneration, hair loss, muscle atrophy, hypoglycemia, etc. To investigate the effect of linagliptin on these aging-related phenotypes, male klotho-/- mice were divided into two groups: (1) control group fed the standard diet, and (2) linagliptin group fed the standard diet containing linagliptin. Treatment with linagliptin was performed for 4 weeks. The effect of linagliptin on the above mentioned aging-related phenotypes was examined. RESULTS: Body weight of klotho-/- mice was greater in linagliptin group than in control group (11.1 ± 0.3 vs 9.9 ± 0.3 g; P < 0.01), which was associated with greater gastrocnemius muscle weight (P < 0.01) and greater kidney weight (P < 0.05) in linagliptin group. Thus, linagliptin significantly prevented body weight loss in klotho-/- mice. Survival rate of klotho-/- mice was greater in linagliptin group (93%) compared to control group (67%), although the difference did not reach statistical significance (P = 0.08). None of linagliptin-treated klotho-/- mice had alopecia during the treatment (P < 0.05 vs control klotho-/- mice). Latency of klotho-/- mice in passive avoidance test was larger in linagliptin group than in control group (P < 0.05), indicating the amelioration of cognitive impairment by linagliptin. Cerebral blood flow of klotho-/- mice was larger in linagliptin group than in control group (P < 0.01), being associated with greater cerebral phospho-eNOS levels (P < 0.05) in linagliptin group. Neuronal cell number in hippocampal CA1 region was greater in linagliptin group than in control group (P < 0.05). Linagliptin group had greater cerebral phospho-Akt (P < 0.05) and phospho-CREB (P < 0.05) than control group. Thus, linagliptin ameliorated brain aging in klotho-/- mice. The degree of hypoglycemia in klotho-/- mice was less in linagliptin group than in control group, as estimated by the findings of OGTT. CONCLUSIONS: Out work provided the evidence that DPP-4 inhibition with linagliptin slowed the progression of premature aging in klotho-/- mice, and provided a novel insight into the potential role of DPP-4 in the mechanism of premature aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s12933-017-0639-y
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Hasegawa, Y., Hayashi, K., Takemoto, Y., Cheng, C., Takane, K., Lin, B., Komohara, Y., & Kim‐Mitsuyama, S. (2017). DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho−/− mice. <em>Cardiovascular Diabetology</em>. https://doi.org/10.1186/s12933-017-0639-y
Vancouver
Hasegawa Y, Hayashi K, Takemoto Y, Cheng C, Takane K, Lin B, et al. DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho−/− mice. Cardiovascular Diabetology. 2017. doi:10.1186/s12933-017-0639-y.
BibTeX
@article{yu2017DPPinh,
title = {DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho−/− mice},
author = {Yu Hasegawa and Kenyu Hayashi and Yushin Takemoto and Cao Cheng and Koki Takane and Bowen Lin and Yoshihiro Komohara and Shokei Kim‐Mitsuyama},
journal = {Cardiovascular Diabetology},
year = {2017},
doi = {10.1186/s12933-017-0639-y},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
medRxiv 2026
Preprint · CC-BY
A Cerebral Frailty Risk Score Integrating Frailty Index and Neuroimaging for Dementia Prediction in the UK Biobank
Connective Tissue Research 2019
Preprint · OA
Naturally occurring osteoarthritis in male mice with an extended lifespan
Journal of Neurochemistry 2005
Citation only
Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease
eLife 2021
Open access · CC-BY
A cross-sectional study of functional and metabolic changes during aging through the lifespan in male mice
Neurobiology of Stress 2021
Open access · CC-BY
Cellular senescence as a driver of cognitive decline triggered by chronic unpredictable stress
Physiological Research 2019
Open access · CC-BY